GH1 and acromegaly: In a case report of X-LAG acromegaly described by Daly et al., PAS succeeded in inhibiting GH-secretion from tumor culture cells while octreotide did not; unfortunately, a limit of the study was that treatment was only tested in culture cells and not in the clinical setting [28].